Recombinant herpes zoster vaccine not checked

Shanghai Institute Of Biological Products

FollowEvery change as it happens, and a Monday email
Stage
 
Next date
None yet
 
Trials
1 active
1 in total

What this is

How it works
How it works isn't classified yet
How it’s given
“Adjuvant control 1, Dose Level 1, Intramuscular injection, 0, 2 months schedule”In the company’s words, NCT06932523 on ClinicalTrials.gov
Tested for
Herpes Zoster (HZ)
Main trialPhase 1/2
“The purpose of this clinical study is to evaluate the safety and immunogenicity of receiving two doses of recombinant herpes zoster vaccine (CHO cells) (RHZV) in healthy individuals aged 40 years and above. This study will be conducted in 2 substudies: Substudy A (Phase I) and Substudy B (Phase Ⅱ).”In the company’s words, NCT06932523 on ClinicalTrials.gov

Other drugs for Herpes Zoster (HZ)

All 19 drugs for Herpes Zoster (HZ)

Coming up0

No dates coming up.

Changes0

Last 90 days

No changes yet. We started recording changes on 6 Nov 2026.

Trials1

TrialPhaseCompletesWhat it tests
Phase 1/2Recruiting 30 Jun 2026 A Study to Evaluate the Safety of Recombinant Herpes Zoster Vaccine for Healthy Individuals
A trial in both registries shows both numbers.

About

Sources
ClinicalTrials.gov updated 18 Nov 2026 · EU trials register (CTIS) updated 18 Nov 2026 · openFDA updated 17 Nov 2026

Follow Recombinant herpes zoster vaccine

Following is part of Solo: you see every change to Recombinant herpes zoster vaccine the day it happens.

Solo

$49a month, excl. VAT

  • Follow up to 5 landscapes, companies or drugs
  • Every change, the day it happens
  • A Monday email with the week’s changes
Choose Solo

Free

$0no card

  • One landscape of your own, in full
  • The top 10 of everything else
Sign up free

Have an account? Sign in